Labels

Back to Forum

This forum has 20 topics, 46 replies, and was last updated 6 months, 2 weeks ago by RichardDaurn.

Viewing 15 topics - 1 through 15 (of 20 total)

- Topics
- Replies
- Author
- Labels for Commercial Products Used in Investigator Initiated Studies (IIS)
- 2
- By Lorna Briddick
- Update of labels and Health Authority grace period
- 2
- By Anonymous
- IMP Labeling – Israel
- 3
- By Anonymous
- Date format for IMP In EU
- 6
- By Anonymous
- Annex VI subject ID/treatment number = kit ID?
- 3
- By Amy Thompson
- Labelling of “post-treatment” commercial available IMP
- 1
- By Anonymous
- Labeling for Canada
- 3
- By Anonymous
- Providing returns bag?
- 1
- By Anonymous
- Shelf life extension labels in China
- 3
- By Anonymous
- Pooled supply at sites – Shipping kits without a specified protocol
- 4
- By Nathan Kohner
- Labeling Powder for oral use
- 2
- By Amy Thompson
- Annex VI Grace Period
- 4
- By Anonymous
- Annex VI Subject/ Visit number as write-in field
- 3
- By Anonymous
- Annex VI – unique blinded vial identifyer instead of blinded batch number?
- 3
- By Anonymous
- Labeling Test Articles for Preclinical studies
- 5
- By Anonymous

Viewing 15 topics - 1 through 15 (of 20 total)

Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.

Join Renew